Transcranial Doppler (TCD) is used to detect children with sickle cell anemia (SCA) who are at risk for stroke, and transfusion programs significantly reduce stroke risk in patients with abnormal TCD. We describe the predictive factors and outcomes of cerebral vasculopathy in the Créteil newborn SCA cohort (n = 217 SS/Sβ0), who were early and yearly screened with TCD since 1992. Magnetic resonance imaging/magnetic resonance angiography was performed every 2 years after age 5 (or earlier in case of abnormal TCD). A transfusion program was recommended to patients with abnormal TCD and/or stenoses, hydroxyurea to symptomatic patients in absence of macrovasculopathy, and stem cell transplantation to those with human leukocyte antigen-genoidentical donor. Mean follow-up was 7.7 years (1609 patient-years). The cumulative risks by age 18 years were 1.9% (95% confidence interval [95% CI] 0.6%-5.9%) for overt stroke, 29.6% (95% CI 22.8%-38%) for abnormal TCD, which reached a plateau at age 9, whereas they were 22.6% (95% CI 15.0%-33.2%) for stenosis and 37.1% (95% CI 26.3%-50.7%) for silent stroke by age 14. Cumulating all events (stroke, abnormal TCD, stenoses, silent strokes), the cerebral risk by age 14 was 49.9% (95% CI 40.5%-59.3%); the independent predictive factors for cerebral risk were baseline reticulocytes count (hazard ratio 1.003/L × 109/L increase, 95% CI 1.000-1.006; P = .04) and lactate dehydrogenase level (hazard ratio 2.78/1 IU/mL increase, 95% CI1.33-5.81; P = .007). Thus, early TCD screening and intensification therapy allowed the reduction of stroke-risk by age 18 from the previously reported 11% to 1.9%. In contrast, the 50% cumulative cerebral risk suggests the need for more preventive intervention.
Key Points: Baseline hemoglobin levels lower than 7 g/dL, acute anemia, and extracranial internal carotid stenosis are significant and independent risk factors for SCI in SCA.
BACKGROUND AND OBJECTIVE: Congenital pulmonary malformations (CPM) are mostly recognized on prenatal ultrasound scans. In a minority of cases, they may impair breathing at birth. The factors predictive of neonatal respiratory distress are not well defined, but an understanding of these factors is essential for decisions concerning the need for the delivery to take place in a tertiary care center. The aim of this study was to identify potential predictors of respiratory distress in neonates with CPM. METHODS: We selected cases of prenatal diagnosis of hyperechoic and/or cystic lung lesions from RespiRare, the French prospective multicenter registry for liveborn children with rare respiratory diseases (2008–2013). Prenatal parameters were correlated with neonatal respiratory outcome. RESULTS: Data were analyzed for 89 children, 22 (25%) of whom had abnormal breathing at birth. Severe respiratory distress, requiring oxygen supplementation or ventilatory support, was observed in 12 neonates (13%). Respiratory distress at birth was significantly associated with the following prenatal parameters: mediastinal shift (P = .0003), polyhydramnios (P = .05), ascites (P = .0005), maximum prenatal malformation area (P = .001), and maximum congenital pulmonary malformation volume ratio (CVR) (P = .001). Severe respiratory distress, requiring oxygen at birth, was best predicted by polyhydramnios, ascites, or a CVR >0.84. CONCLUSIONS: CVR >0.84, polyhydramnios, and ascites increased the risk of respiratory complications at birth in fetuses with CPM, and especially of severe respiratory distress, requiring oxygen supplementation or more intensive intervention. In such situations, the delivery should take place in a tertiary care center.
Stroke risk in sickle-cell-anemia (SCA) is predicted by high transcranial Doppler (TCD) velocities and prevented by chronic transfusions. Nevertheless, chronic transfusions are associated with severe side effects, such as iron overload. We present here the long-term follow-up of SCA-children from the newborn-CHIC-Créteil-cohort (1992-2012), detected at risk by TCD and placed on chronic transfusions. Patients with normalized-velocities and no persistent stenosis were treated with hydroxyurea, which had been shown to decrease anemia, and hemolytic rate, risk-factors for abnormal-TCD. They were followed with trimestrial Doppler and transfusions re-started immediately in case of reversion to abnormal-velocities. Patients with a genoidentical donor underwent transplantation. Abnormal-TCD (TAMMV≥200cm/sec) was detected in 92 SCA-children, at a mean age of 3.7 years/range:1.3-8.3. With a mean follow-up of 6.1 years, no stroke occurred post-transfusion. Normalization of velocities (TAMMV<170cm/sec) was observed in 83.5% of patients. Stenosis, present in 27.5% of patients, was associated with the risk of non-TCD-normalization (HR=2.6,95%CI:1.5-4,p=0.001). Switch from transfusions to hydroxyurea was prescribed to 45 patients for a mean follow-up of 3.4 years. Reversion, predicted by baseline reticulocyte count ≥400×109/L (HR=6.3,95%CI:1.8-21.7,p=0.001), occurred in 13/45 (28.9%) at the mean age of 7.1 years/range:4.3-9.5. Transplantation, performed in 24 patients, allowed transfusions to be safely stopped in all patients and velocities to be normalized in 4 patients who still had abnormal-velocities on transfusions. This long-term cohort study shows that transfusions can be stopped not only in transplanted patients, but also in a subset of patients switched to hydroxyurea, provided trimestrial Doppler follow-up and immediately re-starting transfusions in case of reversion.
About 10–20% of patients with Kawasaki disease (KD) are unresponsive to intravenous immunoglobulin (IVIg) and are at increased risk of coronary artery abnormalities (CAAs). Early identification is critical to initiate aggressive therapies, but available scoring systems lack sensitivity in non-Japanese populations. We investigated the accuracy of 3 Japanese scoring systems and studied factors associated with IVIg unresponsiveness in a large multiethnic French population of children with KD to build a new scoring system. Children admitted for KD between 2011–2014 in 65 centers were enrolled. Factors associated with second line-treatment; i.e. unresponsiveness to initial IVIg treatment, were analyzed by multivariate regression analysis. The performance of our score and the Kobayashi, Egami and Sano scores were compared in our population and in ethnic subgroups. Overall, 465 children were reported by 84 physicians; 425 were classified with KD (55% European Caucasian, 12% North African/Middle Eastern, 10% African/Afro-Caribbean, 3% Asian and 11% mixed). Eighty patients (23%) needed second-line treatment. Japanese scores had poor performance in our whole population (sensitivity 14–61%). On multivariate regression analysis, predictors of secondary treatment after initial IVIG were hepatomegaly, ALT level ≥30 IU/L, lymphocyte count <2400/mm3 and time to treatment <5 days. The best sensitivity (77%) and specificity (60%) of this model was with 1 point per variable and cut-off ≥2 points. The sensitivity remained good in our 3 main ethnic subgroups (74–88%). We identified predictors of IVIg resistance and built a new score with good sensitivity and acceptable specificity in a non-Asian population.
1 May 2008 in American Journal of Respiratory and Critical Care Medicine
Rationale: Contact tracing is an important component of tuberculosis (TB) control programs. Standardization of contact investigation protocols can make them more efficient. Objectives: To develop a model to select contact subjects for screening. Methods: We prospectively collected standardized data on 325 TB index cases and their 2,009 contacts. Factors that independently influenced the risk of TB infection were included in the model, which was then validated in a second prospective cohort of 88 cases of TB and their 618 contacts. Measurements and Main Results: A total of eight independent risk factors were identified (odds ratio; 95% confidence interval): age, with three subgroups: 6–14 years (3.6; 1.6–8.0); 15–29 years (3.7; 1.8–7.7); ≥30 years (4.1; 2.0–8.5); cavitation on the index case's chest radiograph (1.6; 1.1–2.2); an index case sputum smear with 100 or more acid-fast bacilli per field (1.8; 1.2–2.8); household contact at night (2.1; 1.3–3.2); first-degree family relationship with the index case (2.1; 1.3–3.3); active smoking by the contact (1.6; 1.1–2.4); free health care (2.0; 1.2–3.2); and birth in a country with TB incidence rate higher than 25 of 100,000 (2.2; 1.5–3.2). Predictive probabilities were chosen to ensure false-negative rates lower than estimated TB infection background. The number of contacts to be investigated was reduced by 26% while maintaining a false-negative rate of 8%. Conclusions: This study provides a standardized contact screening model which reduces resources required without negatively affecting disease control.